Two medical doctors charged with acquiring controlled substances by fraud and identity theft
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Two medical doctors charged with acquiring controlled substances by fraud and identity theft

Two medical doctors charged with acquiring controlled substances by fraud and identity theft

Septiembre 26, 2019
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Miami.FD.PIO@dea.gov
Phone Number: (571) 362-3364 - Option 5

PENSACOLA, Fla. - Robert Patrick Jensen, 49, and Michael T. Harris, 44, both of Gulf Breeze, Florida, appeared in federal court this week for their initial appearances after they were indicted by a federal grand jury in Pensacola on charges of acquiring controlled substances by fraud and identity theft.

 

The indictment charging Jensen alleges that between December 3, 2014, and July 7, 2016, he knowingly acquired and obtained controlled substances – namely tramadol and dextroamphetamine – by misrepresentation, fraud, forgery, deception, and subterfuge. The indictment also alleges that between those same dates, Jensen knowingly and unlawfully used another person’s identification to acquire the controlled substances by fraud.

 

The indictment charging Harris alleges that between November 4, 2015, and August 11, 2016, he knowingly acquired and obtained controlled substances – methadone, morphine sulfate, oxycodone, and alprazolam – by misrepresentation, fraud, forgery, deception, and subterfuge. The indictment also alleges that between those same dates, Harris knowingly and unlawfully used another person’s identification to acquire the controlled substances by fraud.

 

Jensen and Harris each face the following potential penalties:

• For acquiring controlled substances by fraud, a maximum of four years in prison.

• For identity theft, a maximum of 20 years in prison.

 

This case was investigated by the Drug Enforcement Administration's Tallahassee Resident Office, the Santa Rosa County Sheriff’s Office, and the Gulf Breeze Police Department. It is being prosecuted byt the United States Attorney’s Office for the Northern District of Florida.  

 

More information about this case can be found at www.flnd.uscourts.gov

Download Press Release
###
Amphetamines
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Deanne L. Reuter Special Agent in Charge - Miami
@deamiamidiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster